Hims & Hers Health Faces Securities Class Action Lawsuit

Hims & Hers Health, Inc. (NYSE: HIMS) and some of its executives are now subject to a securities class action lawsuit. This action stems from a federal complaint filed by the U.S. Federal Trade Commission (FTC), which accuses Hims & Hers of serious business practices.

The FTC's allegations specifically target the company's treatments for sexual health and their marketing. The complaint asserts that Hims & Hers misled consumers and employed inappropriate methods to generate profits.

Investors who have experienced substantial losses due to a decline in the stock value of Hims & Hers Health have an opportunity to lead this class action lawsuit. The deadline to join or initiate the legal action is November 2, 2026.

The securities class action aims to recover damages for investors. The company's stock has seen a notable decrease in value since the FTC's allegations became public, raising concerns among shareholders.